New unit president appointed as Patheon closes Banner acquisition
This article was originally published in Scrip
Executive Summary
Patheon has appointed a new president to head its proprietary products business unit, Geoff Glass, on the back of completing a $255 million acquisition of the gelatin-based formulations manufacturer Banner Pharmacaps.